Vis enkel innførsel

dc.contributor.advisorLeiros, Hanna-Kirsti S.
dc.contributor.authorSkagseth, Susann
dc.date.accessioned2017-03-16T08:50:17Z
dc.date.available2017-03-16T08:50:17Z
dc.date.issued2017-02-16
dc.description.abstractThis thesis focuses on metallo-β-lactamases (MBLs) enzymes that break down a wide variety of antibiotics. Bacteria harboring genes expressing MBLs are antibiotic resistant. If the MBL genes are found on mobile genetic elements, the spread of the genes between bacteria becomes easier. To date, there are no MBL inhibitors available for blocking the enzyme activity, and thus there is an urgent need to find such inhibitors. In order to understand how the MBL enzymes work, information on residues important for the enzyme activity is valuable. The importance of different residues located in or close to the active site of selected MBLs and the search for MBL inhibitors in synthetically made compounds were investigated. This was performed using enzyme kinetics studies, thermostability measurements, MIC determination, cellular assay, modelling studies, in silico calculations and crystallography. The substitution of a zinc-binding residue resulted in loss of one active site zinc and the ability for the enzyme to hydrolyze β-lactam antibiotics. Substitutions of second sphere residues contributed in tuning the substrate specificity of the MBL enzymes. Certain second sphere substitutions introduced more hydrogen bonds, which increased the catalytic activity and the temperature stability of the mutants. Other substitutions revealed a reduction in catalytic efficiency, showing that the residues are important, however, not essential for the enzyme activity. The thiol-based synthesized inhibitors studied in this thesis revealed potent inhibitors with inhibitory effects in the low micro- and nanomolar range. These inhibitors are good starting points for further inhibitors optimization, preferably broad spectrum inhibitors.en_US
dc.description.doctoraltypeph.d.en_US
dc.description.popularabstractBacteria has acquired genes enabling them express enzymes called metallo-β-lactamases (MBLs) that break down a wide variety of antibiotics, creating multi-resistant bacteria. In my thesis, I have studied some of the MBL enzymes in order to get a broader understanding of how they work. Selected amino acids have been replaced in the enzymes, their new activity tested and the structure investigated. Knowledge of which amino acids are important for their ability to break down antibiotics can be used to create inhibitory compounds (inhibitors) for blocking the enzymes activity. The inhibitors may contribute to restore the function of antibiotics, and can be used together with antibiotics in treatments to fight these multi-resistant superbugs. A goal is to develop inhibitors that can block a broad spectrum of enzymes. Our results have shown that the selected amino acids are residue determinants, they affect antibiotic specificity of the MBL enzymes studied. The inhibitors investigated showed promising effect specifically on one enzyme, and not of other enzymes examined. The developed inhibitors can provide a starting point for further compound optimization for targeting a broader spectrum of enzymes.en_US
dc.description.sponsorshipFriMedBio 213808, The Norwegian Research Council. UiT – The Arctic University of Norway.en_US
dc.descriptionThe papers III and IV are not available in Munin. <br> Paper III: Skagseth, S., Akhter, S., Paulsen, M. H., Samuelsen, Ø., Muhammad, Z., Leiros, H-K. S., Bayer, A.: “Metallo-β-lactamase Inhibitors by Bioisosteric Replacement: Preparation, Activity and Binding”. (Manuscript). Published version available in <a href=https://doi.org/10.1016/j.ejmech.2017.04.035> European Journal of Medicinal Chemistry 2017, 135:159–173. </a> <br> Paper IV: Skagseth, S., Christopeit, T., Akhter, S., Bayer, A., Samuelsen, Ø., Leiros, H-K. S.: “Structural insight into TMB-1 and the role of residue 119 and 228 in substrate and inhibitor activity”. (Manuscript). Published version available in <a href=http://dx.doi.org/10.1128/AAC.02602-16> Antimicrob. Agents Chem. 2017. </a>en_US
dc.identifier.isbn978-82-8236-244-3 (trykt) og 978-82-8236-245-0 (pdf)
dc.identifier.urihttps://hdl.handle.net/10037/10724
dc.language.isoengen_US
dc.publisherUiT Norges arktiske universiteten_US
dc.publisherUiT The Arctic University of Norwayen_US
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2017 The Author(s)
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/3.0en_US
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0)en_US
dc.subjectVDP::Mathematics and natural science: 400::Chemistry: 440en_US
dc.subjectVDP::Matematikk og Naturvitenskap: 400::Kjemi: 440en_US
dc.titleMutational, structural and inhibitory investigations of metallo-β-lactamases involved in antibiotic resistanceen_US
dc.typeDoctoral thesisen_US
dc.typeDoktorgradsavhandlingen_US


Tilhørende fil(er)

Thumbnail
Thumbnail
Thumbnail
Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0)
Med mindre det står noe annet, er denne innførselens lisens beskrevet som Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0)